Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Geratherm Medical AG's earnings per share without non-recurring items for the
six
months ended in Dec. 2025 was €0.01.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.00.
During the past 12 months, Geratherm Medical AG's average earnings per share (NRI) Growth Rate was -89.40% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -55.90% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -22.60% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was -11.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Geratherm Medical AG's EPS without NRI or its related term are showing as below:
XTER:GME'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -63.5 Med: 3.9 Max: 158.7
Current: -55.9
During the past 13 years, Geratherm Medical AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 158.70% per year. The lowest was -63.50% per year. And the median was 3.90% per year.
XTER:GME's 3-Year EPS without NRI Growth Rate is ranked worse than 96.82% of 660
companies
in the Medical Devices & Instruments industry
Industry Median: 8.25
vs XTER:GME: -55.90
Geratherm Medical AG's EPS (Basic) for the
six
months ended in Dec. 2025 was €-0.11.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.15.
Geratherm Medical AG (XTER:GME) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Geratherm Medical AG EPS without NRI Related Terms
Geratherm Medical AG EPS without NRI Historical Data
* Premium members only.
The historical data trend for Geratherm Medical AG's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:GME vs ABT, SYK, MDT: EPS without NRI Comparison
For the Medical Devices subindustry, Geratherm Medical AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Geratherm Medical AG PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Geratherm Medical AG's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Geratherm Medical AG (XTER:GME) has a EPS without NRI of €-0.00 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Geratherm Medical AG and its competitors. According to the industry distribution chart, Geratherm Medical AG ranks #639 out of 660 companies in the Medical Devices & Instruments industry, placing it in the top 96.8%.
Is Geratherm Medical AG's EPS without NRI too high?
Geratherm Medical AG's current EPS without NRI is €-0.00. Based on the distribution chart, Geratherm Medical AG ranks #639 out of 660 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Geratherm Medical AG has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Geratherm Medical AG's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Geratherm Medical AG ranks #639 out of 660 companies for EPS without NRI. This places Geratherm Medical AG in the lower half of its industry. The industry median EPS without NRI is 8.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.25, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Geratherm Medical AG and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Geratherm Medical AG's current EPS without NRI is €-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Geratherm Medical AG stock overvalued right now?
Based on GuruFocus' analysis, Geratherm Medical AG (XTER:GME) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.16, compared to a current price of €2.62 — trading 17.1% below its estimated fair value. The current EPS without NRI is €-0.00. Geratherm Medical AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Geratherm Medical AG (XTER:GME), the current EPS without NRI is €-0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Geratherm Medical AG (XTER:GME) Overvalued in 2026?
Based on GuruFocus' analysis, Geratherm Medical AG stock appears to be undervalued.
The current stock price of €2.62 is trading 17.1% below its estimated GF Value™ of €3.16.
GuruFocus considers Geratherm Medical AG to be Modestly Undervalued.
Key valuation signals for XTER:GME:
EPS without NRI: €-0.00
GF Value™: €3.16 vs. price of €2.62 (17.1% below fair value)
No single metric tells the full story. See the XTER:GME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
72GF Score
Get the complete analysis for XTER:GME
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:GME has been successfully added to your 
